INTRODUCTION: Many patients with Parkinson's disease (PD) report daytime sleepiness. Its etiology, however, is still not fully understood. The aim of this study was to examine if the amount of nigrostriatal dopaminergic degeneration is associated with subjective daytime sleepiness in patients with PD. PATIENTS AND METHODS: We investigated 21 patients with PD clinically and by means of [(123)I] FP-CIT-SPECT (DaTSCAN(R)). Each patient filled in the Epworth sleepiness scale (ESS), the Parkinson's Disease Sleep Scale (PDSS), and the self-rating depression scale according to Zung (SDS) to assess sleepiness, sleep quality, and depressive symptoms. RESULTS: The mean specific dopamine transporter binding in the 21 PD patients (60.8 +/- 10.4 years, nine females, median Hoehn and Yahr stage 2.0) was decreased. Nine patients were in Hoehn and Yahr stage 1 (58.7 +/- 6.6 years, four females; ESS score 7.4 +/- 4.5; PDSS score 105.1 +/- 30.9), the other 12 patients were in Hoehn and Yahr stage 2 (62.4 +/- 12.6 years, five females; ESS score 6.7 +/- 4.7, PDSS score 97.1 +/- 25.6). Age, gender, ESS, and PDSS scores were not significantly different in both groups. However, ESS scores showed an inverse correlation with mean DAT binding in the striatum (r = -0.627, p = 0.03), the caudate nucleus (r = -0.708, p = 0.01), and the putamen (r = -0.599, p = 0.04) in patients with Hoehn and Yahr stage 2. There was no correlation of the ESS score with age, disease duration, UPDRS motor score, PDSS score, or depression score. CONCLUSION: Subjective daytime sleepiness seems to be associated with dopaminergic nigrostriatal degeneration in early PD.
INTRODUCTION: Many patients with Parkinson's disease (PD) report daytime sleepiness. Its etiology, however, is still not fully understood. The aim of this study was to examine if the amount of nigrostriatal dopaminergic degeneration is associated with subjective daytime sleepiness in patients with PD. PATIENTS AND METHODS: We investigated 21 patients with PD clinically and by means of [(123)I] FP-CIT-SPECT (DaTSCAN(R)). Each patient filled in the Epworth sleepiness scale (ESS), the Parkinson's Disease Sleep Scale (PDSS), and the self-rating depression scale according to Zung (SDS) to assess sleepiness, sleep quality, and depressive symptoms. RESULTS: The mean specific dopamine transporter binding in the 21 PDpatients (60.8 +/- 10.4 years, nine females, median Hoehn and Yahr stage 2.0) was decreased. Nine patients were in Hoehn and Yahr stage 1 (58.7 +/- 6.6 years, four females; ESS score 7.4 +/- 4.5; PDSS score 105.1 +/- 30.9), the other 12 patients were in Hoehn and Yahr stage 2 (62.4 +/- 12.6 years, five females; ESS score 6.7 +/- 4.7, PDSS score 97.1 +/- 25.6). Age, gender, ESS, and PDSS scores were not significantly different in both groups. However, ESS scores showed an inverse correlation with mean DAT binding in the striatum (r = -0.627, p = 0.03), the caudate nucleus (r = -0.708, p = 0.01), and the putamen (r = -0.599, p = 0.04) in patients with Hoehn and Yahr stage 2. There was no correlation of the ESS score with age, disease duration, UPDRS motor score, PDSS score, or depression score. CONCLUSION: Subjective daytime sleepiness seems to be associated with dopaminergic nigrostriatal degeneration in early PD.
Authors: Paul Christian Baier; Pablo Branisa; Reinhard Koch; Jan Schindehütte; Walter Paulus; Claudia Trenkwalder Journal: Exp Brain Res Date: 2006-01-24 Impact factor: 1.972
Authors: Ilonka Eisensehr; Reiner Linke; Klaus Tatsch; Bita Kharraz; Josef F Gildehaus; Christian T Wetter; Claudia Trenkwalder; Johannes Schwarz; Soheyl Noachtar Journal: Sleep Date: 2003-08-01 Impact factor: 5.849
Authors: Eva Havlikova; Jitse P van Dijk; Iveta Nagyova; Jaroslav Rosenberger; Berrie Middel; Tatiana Dubayova; Zuzana Gdovinova; Johan W Groothoff Journal: J Neurol Date: 2011-05-26 Impact factor: 4.849
Authors: David T Plante; Rasmus M Birn; Erin C Walsh; Roxanne M Hoks; M Daniela Cornejo; Heather C Abercrombie Journal: J Affect Disord Date: 2017-11-14 Impact factor: 4.839
Authors: Amy W Amara; Lama M Chahine; Chelsea Caspell-Garcia; Jeffrey D Long; Christopher Coffey; Birgit Högl; Aleksandar Videnovic; Alex Iranzo; Geert Mayer; Nancy Foldvary-Schaefer; Ron Postuma; Wolfgang Oertel; Shirley Lasch; Ken Marek; Tanya Simuni Journal: J Neurol Neurosurg Psychiatry Date: 2017-05-29 Impact factor: 10.154
Authors: Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Christopher Wong; Jim Ma; Kith Pradhan; Dardo Tomasi; Peter K Thanos; Sergi Ferré; Millard Jayne Journal: J Neurosci Date: 2008-08-20 Impact factor: 6.167
Authors: Gennaro Pagano; Sophie Molloy; Peter G Bain; Eugenii A Rabiner; K Ray Chaudhuri; David J Brooks; Nicola Pavese Journal: Neurology Date: 2016-11-02 Impact factor: 9.910
Authors: Julien Vezoli; Karim Fifel; Vincent Leviel; Colette Dehay; Henry Kennedy; Howard M Cooper; Claude Gronfier; Emmanuel Procyk Journal: PLoS One Date: 2011-08-24 Impact factor: 3.240